Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer

20261 citationsJournal Article

Authors

Oxybutynin is superior to a placebo for the management of ADT-associated hot flashes in men with prostate cancer.

Published in: Journal of Clinical Oncology

Field-Weighted Citation Impact: 36.61